Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Smith & Nephew plc (SNN)

50.45   -1.19 (-2.3%) 02-21 16:02
Open: 50.48 Pre. Close: 51.64
High: 50.63 Low: 50.185
Volume: 566,771 Market Cap: 21871M
Smith & Nephew PLC designs, manufactures, and markets orthopedic devices and wound-care solutions. Its products include knee replacements, hip implants, nails, fixation devices, arthroscopy tools and others.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 50.671 - 50.927 50.927 - 51.091
Low: 49.569 - 49.914 49.914 - 50.135
Close: 49.956 - 50.476 50.476 - 50.808

Technical analysis

as of: 2020-02-21 4:33:58 PM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 61.04     One year: 71.29
Support: Support1: 49.11    Support2: 47.16
Resistance: Resistance1: 52.26    Resistance2: 61.04
Pivot: 48.59
Moving Average: MA(5): 49.23     MA(20): 48.89
MA(100): 46.45     MA(250): 44.37
MACD: MACD(12,26): 0.32     Signal(9): 0.16
Stochastic oscillator: %K(14,3): 62.56     %D(3): 47.13
RSI: RSI(14): 61.22
52-week: High: 52.26  Low: 37.69  Change(%): 31.9
Average Vol(K): 3-Month: 55988  10-Days: 56607

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
SNN has closed below upper band by 5.2%. Bollinger Bands are 19.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 20 Feb 2020 15:00:00 +0000
Validea Peter Lynch Strategy Daily Upgrade Report - 2/20/2020

Thu, 20 Feb 2020 07:51:31 +0000
Smith & Nephew FY19 Earnings Down 10%; Revenue Rises - Quick Facts

Fri, 24 Jan 2020 07:18:11 +0000
Smith+Nephew Buys Tula System Developer Tusker Medical; Terms Not Disclosed

Thu, 06 Apr 2017 07:25:37 +0000
The 7 Best Retirement Stocks That No One Talks About

Thu, 31 Oct 2019 07:59:07 +0000
Smith+Nephew Q3 Revenues Rise; Lifts FY19 Underlying Revenue Growth View

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 437.60
Shares Float (M) 435.72
% Held by Insiders 0.03
% Held by Institutions 9.40
Shares Short (K) 904
Shares Short P. Month (K)

Stock Financials

EPS 1.590
Book Value (p.s.) 11.310
PEG Ratio
Profit Margin 14.10
Operating Margin 20.53
Return on Assets (ttm) 7.6
Return on Equity (ttm) 14.6
Qtrly Rev. Growth 1.8
Gross Profit (p.s.) 8.250
Sales Per Share
EBITDA (p.s.) 3.199
Qtrly Earnings Growth 12.80
Operating Cash Flow (M) 1080.00
Levered Free Cash Flow (M) 615.50

Stock Valuations

P/E 31.73
P/E Growth Ratio -0.02
P/BV 4.46
P/S 4.45
P/CF 20.44

Dividends & Splits

Dividend 0.360
Dividend Yield 0.01
Dividend Pay Date 2019-10-29
Ex-Dividend Date 2019-10-02
Forward Dividend 0.730
Last Split Date 2014-10-14
Last Split Ratio 2.5
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.